相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Periodontal bacteria in the brain-Implication for Alzheimer's disease: A systematic review
Valeria Parra-Torres et al.
ORAL DISEASES (2023)
Oral Administration of Resveratrol-Selenium-Peptide Nanocomposites Alleviates Alzheimer's Disease-like Pathogenesis by Inhibiting Aβ Aggregation and Regulating Gut Microbiota
Changjiang Li et al.
ACS APPLIED MATERIALS & INTERFACES (2021)
Evidence and Therapeutic Perspectives in the Relationship between the Oral Microbiome and Alzheimer's Disease: A Systematic Review
Yoann Maitre et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
Can we learn lessons from the FDA's approval of aducanumab?
Kathy Y. Liu et al.
NATURE REVIEWS NEUROLOGY (2021)
Revisiting FDA Approval of Aducanumab
G. Caleb Alexander et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Synthesis of human amyloid restricted to liver results in an Alzheimer disease-like neurodegenerative phenotype
Virginie Lam et al.
PLOS BIOLOGY (2021)
Oral microbiota and Alzheimer's disease: Do all roads lead to Rome?
Antoni Sureda et al.
PHARMACOLOGICAL RESEARCH (2020)
Synergy between amyloid-β and tau in Alzheimer's disease
Marc Aurel Busche et al.
NATURE NEUROSCIENCE (2020)
Invite Review - Understanding cause and effect in Alzheimer's pathophysiology: Implications for clinical trials
D. Boche et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2020)
Artificial intelligence in drug combination therapy
Igor F. Tsigelny
BRIEFINGS IN BIOINFORMATICS (2019)
Dynamic Targeting in Cancer Treatment
Zhihui Wang et al.
FRONTIERS IN PHYSIOLOGY (2019)
Modeling HIV Dynamics Under Combination Therapy with Inducers and Antibodies
Chao Yan et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2019)
Alzheimer's disease: pathogenesis, diagnostics, and therapeutics
Sneham Tiwari et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Mathematical model predicts anti-adhesion-antibiotic-debridement combination therapies can clear an antibiotic resistant infection
Paul A. Roberts et al.
PLOS COMPUTATIONAL BIOLOGY (2019)
Prospects and challenges of imaging neuroinflammation beyond TSPO in Alzheimer's disease
Delphine Boche et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options
Jeffrey L. Cummings et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Tau impairs neural circuits, dominating amyloid-beta effects, in Alzheimer models in vivo
Marc Aurel Busche et al.
NATURE NEUROSCIENCE (2019)
Brain-Gut-Microbiota Axis in Alzheimer's Disease
Karol Kowalski et al.
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2019)
Combination Therapy and the Evolution of Resistance: The Theoretical Merits of Synergism and Antagonism in Cancer
Elysia C. Saputra et al.
CANCER RESEARCH (2018)
Molecular targeted therapy: Treating cancer with specificity
Yeuan Ting Lee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Nutritional patterns associated with the maintenance of neurocognitive functions and the risk of dementia and Alzheimer's disease: A focus on human studies
Francesca Pistollato et al.
PHARMACOLOGICAL RESEARCH (2018)
Near-atomic model of microtubule-tau interactions
Elizabeth H. Kellogg et al.
SCIENCE (2018)
Cromolyn Reduces Levels of the Alzheimer's Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis
Can Zhang et al.
SCIENTIFIC REPORTS (2018)
Alzheimer Disease
John E. Morley et al.
CLINICS IN GERIATRIC MEDICINE (2018)
Combination therapy with anti-HIV-1 antibodies maintains viral suppression
Pilar Mendoza et al.
NATURE (2018)
Can an Infection Hypothesis Explain the Beta Amyloid Hypothesis of Alzheimer's Disease?
Tamas Fulop et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
New insights into the role of TREM2 in Alzheimer's disease
Maud Gratuze et al.
MOLECULAR NEURODEGENERATION (2018)
Triple-combination therapy in the treatment of hypertension: a review of the evidence
R. Duesing et al.
JOURNAL OF HUMAN HYPERTENSION (2017)
Combination products: modernizing the regulatory paradigm
Nina L. Hunter et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
Janet Woodcock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Combination therapy of cancer with cancer vaccine and immune checkpoint inhibitors: A mathematical model
Xiulan Lai et al.
PLOS ONE (2017)
A beta-amyloid and Tau Imaging in Dementia
Victor L. Villemagne et al.
SEMINARS IN NUCLEAR MEDICINE (2017)
Alzheimer's disease and metabolic syndrome: A link from oxidative stress and inflammation to neurodegeneration
Eduardo Rojas-Gutierrez et al.
SYNAPSE (2017)
Exploring the Association between Alzheimer's Disease, Oral Health, Microbial Endocrinology and Nutrition
Alice Harding et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
Defective Insulin Signalling, Mediated by Inflammation, Connects Obesity to Alzheimer Disease; Relevant Pharmacological Therapies and Preventive Dietary Interventions
Arantxa Rodriguez-Casado et al.
CURRENT ALZHEIMER RESEARCH (2017)
Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy
Adam C. Palmer et al.
CELL (2017)
Metabolic network failures in Alzheimer's disease: A biochemical road map
Jon B. Toledo et al.
ALZHEIMERS & DEMENTIA (2017)
Combination therapy for melanoma with BRAF/MEK inhibitor and immune checkpoint inhibitor: a mathematical model
Xiulan Lai et al.
BMC SYSTEMS BIOLOGY (2017)
Drug candidates in clinical trials for Alzheimer's disease
Shih-Ya Hung et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Enhanced Tau Aggregation in the Presence of Amyloid β
Rachel E. Bennett et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
The DIAN-TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model
Randall J. Bateman et al.
ALZHEIMERS & DEMENTIA (2017)
Inflammaging decreases adaptive and innate immune responses in mice and humans
Daniela Frasca et al.
BIOGERONTOLOGY (2016)
Challenges, solutions, and recommendations for Alzheimer's disease combination therapy
James A. Hendrix et al.
ALZHEIMERS & DEMENTIA (2016)
The Gut-Brain Axis, Including the Microbiome, Leaky Gut and Bacterial Translocation: Mechanisms and Pathophysiological Role in Alzheimer's Disease
Cristiano A. Kohler et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults
Siobhan M. Hoscheidt et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Microglial immunophenotype in dementia with Alzheimer's pathology
Thais Minett et al.
JOURNAL OF NEUROINFLAMMATION (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series
Natalie S. Ryan et al.
LANCET NEUROLOGY (2016)
Role of metabolism in neurodegenerative disorders
Claudio Procaccini et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
Johannes F. Scheid et al.
NATURE (2016)
Treatment of Alzheimer disease using combination therapy with plasma exchange and haemapheresis with albumin and intravenous immunoglobulin: Rationale and treatment approach of the AMBAR (Alzheimer Management By Albumin Replacement) study
M. Boada et al.
NEUROLOGIA (2016)
Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease
Francesca Pistollato et al.
NUTRITION REVIEWS (2016)
Therapeutic strategies for Alzheimer's disease in clinical trials
Justyna Godyn et al.
PHARMACOLOGICAL REPORTS (2016)
Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis
Annie Christine Lajoie et al.
LANCET RESPIRATORY MEDICINE (2016)
Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection
Milos D. Ikonomovic et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans
Ju-Hee Kang et al.
ALZHEIMERS & DEMENTIA (2015)
Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
Osama Sabri et al.
ALZHEIMERS & DEMENTIA (2015)
The combination of lithium and L-Dopa/Carbidopa reduces MPTP-induced abnormal involuntary movements (AIMs) via calpain-1 inhibition in a mouse model: Relevance for Parkinson's disease therapy
Carol A. Lazzara et al.
BRAIN RESEARCH (2015)
Pancreatic Cancer Combination Therapy Using a BH3 Mimetic and a Synthetic Tetracycline
Bridget A. Quinn et al.
CANCER RESEARCH (2015)
Antibiotics, Pediatric Dysbiosis, and Disease
Pajau Vangay et al.
CELL HOST & MICROBE (2015)
Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation
Anastasia I. Petra et al.
CLINICAL THERAPEUTICS (2015)
Non-Celiac Gluten Sensitivity Triggers Gut Dysbiosis, Neuroinflammation, Gut-Brain Axis Dysfunction, and Vulnerability for Dementia
Mak A. Daulatzai
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2015)
Environment, epigenetics and neurodegeneration: Focus on nutrition in Alzheimer's disease
Vincenzina Nicolia et al.
EXPERIMENTAL GERONTOLOGY (2015)
The optimal combination therapy for the treatment of early rheumatoid arthritis
Diederik De Cock et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Building a roadmap for developing combination therapies for Alzheimer's disease
Daniel Perry et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Clearance systems in the brain-implications for Alzheimer disease
Jenna M. Tarasoff-Conway et al.
NATURE REVIEWS NEUROLOGY (2015)
Immune attack: the role of inflammation in Alzheimer disease
Frank L. Heppner et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Modeling the Role of the Glymphatic Pathway and Cerebral Blood Vessel Properties in Alzheimer's Disease Pathogenesis
Christina Rose Kyrtsos et al.
PLOS ONE (2015)
Building a roadmap for developing combination therapies for Alzheimer's disease
Daniel Perry et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Safety and Efficacy of Rasagiline in Addition to Levodopa for the Treatment of Idiopathic Parkinson's Disease: A Meta-Analysis of Randomised Controlled Trials
Jiang-Ping Cai et al.
EUROPEAN NEUROLOGY (2015)
Charting a path toward combination therapy for Alzheimer's disease
Diane Stephenson et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Nutraceuticals and amyloid neurodegenerative diseases: a focus on natural phenols
Stefania Rigacci et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
A Food and Drug Administration-approved Asthma Therapeutic Agent Impacts Amyloid β in the Brain in a Transgenic Model of Alzheimer Disease
Yukiko Hori et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Nutrient patterns and brain biomarkers of Alzheimer's disease in cognitively normal individuals
V. Berti et al.
JOURNAL OF NUTRITION HEALTH & AGING (2015)
Mechanisms of Molecular Mimicry Involving the Microbiota in Neurodegeneration
Robert P. Friedland
JOURNAL OF ALZHEIMERS DISEASE (2015)
Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease
Sergio T. Ferreira et al.
ALZHEIMERS & DEMENTIA (2014)
Brain metabolic dysfunction at the core of Alzheimer's disease
Suzanne M. de la Monte et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Beneficial properties of natural phenols: Highlight on protection against pathological conditions associated with amyloid aggregation
Massimo Stefani et al.
BIOFACTORS (2014)
Pathways to Alzheimer's disease
J. Hardy et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging
Eduardo Rigon Zimmer et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Chronic Functional Bowel Syndrome Enhances Gut-Brain Axis Dysfunction, Neuroinflammation, Cognitive Impairment, and Vulnerability to Dementia
Mak Adam Daulatzai
NEUROCHEMICAL RESEARCH (2014)
Role of plant-based diets in the prevention and regression of metabolic syndrome and neurodegenerative diseases
Francesca Pistollato et al.
TRENDS IN FOOD SCIENCE & TECHNOLOGY (2014)
Alzheimer's disease drug-development pipeline: few candidates, frequent failures
Jeffrey L. Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Fold modulating function: bacterial toxins to functional annyloids
Adnan K. Syed et al.
FRONTIERS IN MICROBIOLOGY (2014)
The genetics of Alzheimer's disease
Eva Bagyinszky et al.
CLINICAL INTERVENTIONS IN AGING (2014)
Much of Late Life Cognitive Decline Is Not due to Common Neurodegenerative Pathologies
Patricia A. Boyle et al.
ANNALS OF NEUROLOGY (2013)
Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer's Disease
Muriel Noetzli et al.
CLINICAL PHARMACOKINETICS (2013)
The Multifactorial Nature of Alzheimer's Disease for Developing Potential Therapeutics
M. Carmo Carreiras et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
The intricate association between gut microbiota and development of Type 1, Type 2 and Type 3 diabetes
Pjotr Bekkering et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2013)
What causes Alzheimer's disease?
Richard A. Armstrong
FOLIA NEUROPATHOLOGICA (2013)
Food, Nutrigenomics, and Neurodegeneration-Neuroprotection by What You Eat!
Ashraf Virmani et al.
MOLECULAR NEUROBIOLOGY (2013)
CANCER Calculated treatment
Natalia L. Komarova et al.
NATURE (2013)
Neuroinflammatory phenotype in early Alzheimer's disease
Tiffany L. Sudduth et al.
NEUROBIOLOGY OF AGING (2013)
The influence of diet on the gut microbiota
Karen P. Scott et al.
PHARMACOLOGICAL RESEARCH (2013)
Alzheimer disease A tale of two prions
Justin M. Nussbaum et al.
PRION (2013)
Potential benefits of adherence to the Mediterranean diet on cognitive health
Catherine Feart et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2013)
Therapeutic management in early disease stages of systemic sclerosis. Early diagnosis - early symptoms - early problems
M. Frerix et al.
ZEITSCHRIFT FUR RHEUMATOLOGIE (2013)
Paravascular microcirculation facilitates rapid lipid transport and astrocyte signaling in the brain
Vinita Rangroo Thrane et al.
SCIENTIFIC REPORTS (2013)
Evolutionary dynamics of cancer in response to targeted combination therapy
Ivana Bozic et al.
ELIFE (2013)
Inflammatory process in Alzheimer's Disease
Marco A. Meraz-Rios et al.
FRONTIERS IN INTEGRATIVE NEUROSCIENCE (2013)
Is RAGE still a therapeutic target for Alzheimer's disease?
Richard J. Deane
FUTURE MEDICINAL CHEMISTRY (2012)
Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study
David H. Cribbs et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
John F. Cryan et al.
NATURE REVIEWS NEUROSCIENCE (2012)
A Unifying Role for Prions in Neurodegenerative Diseases
Stanley B. Prusiner
SCIENCE (2012)
A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
Jose Miguel Rubio-Perez et al.
SCIENTIFIC WORLD JOURNAL (2012)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Evidence for Ordering of Alzheimer Disease Biomarkers
Clifford R. Jack et al.
ARCHIVES OF NEUROLOGY (2011)
Are Tangles as Toxic as They Look?
Tara L. Spires-Jones et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
Robust Amyloid Clearance in a Mouse Model of Alzheimer's Disease Provides Novel Insights into the Mechanism of Amyloid-β Immunotherapy
Allan Wang et al.
JOURNAL OF NEUROSCIENCE (2011)
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS--ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
G. McKhann et al.
NEUROLOGY (2011)
Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome
Nathalie M. Delzenne et al.
MICROBIAL CELL FACTORIES (2011)
Diet Drives Convergence in Gut Microbiome Functions Across Mammalian Phylogeny and Within Humans
Brian D. Muegge et al.
SCIENCE (2011)
Neuropathological Alterations in Alzheimer Disease
Alberto Serrano-Pozo et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Aβ42 immunisation in Alzheimer's disease
Delphine Boche et al.
ACTA NEUROPATHOLOGICA (2010)
Molecular mechanisms of neurodegeneration in Alzheimer's disease
Leslie Crews et al.
HUMAN MOLECULAR GENETICS (2010)
Role of Mitochondrial Amyloid-beta in Alzheimer's Disease
John Xi Chen et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Neuropathology of Alzheimer's Disease
Daniel P. Perl
MOUNT SINAI JOURNAL OF MEDICINE (2010)
Neurochemical basis for symptomatic treatment of Alzheimer's disease
Paul T. Francis et al.
NEUROPHARMACOLOGY (2010)
Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease
Lesley Jones et al.
PLOS ONE (2010)
The Neuropathology of Probable Alzheimer Disease and Mild Cognitive Impairment
Julie A. Schneider et al.
ANNALS OF NEUROLOGY (2009)
Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship
Peter T. Nelson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Uptake and Dynamics of Infectious Prion Protein in the Intestine
Yasuhisa Ano et al.
PROTEIN AND PEPTIDE LETTERS (2009)
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT
Rob Jones et al.
TRIALS (2009)
Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis
Scott A. Small et al.
NEURON (2008)
Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice
Lisa McConlogue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Common inflammatory mechanisms in Lewy body disease and Alzheimer disease
Robert E. Mrak et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2007)
Cardiovascular risk factors for Alzheimer's disease
Clive Rosendoff et al.
AMERICAN JOURNAL OF GERIATRIC CARDIOLOGY (2007)
The significance of the cholinergic system in the brain during aging and in Alzheimer's disease
R. Schliebs et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
From benefit to damage. Glutamate and advanced glycation end products in Alzheimer brain
P. Riederer et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain
M Ingelsson et al.
NEUROLOGY (2004)
Soluble Aβ homeostasis in AD and DS:: impairment of anti-amyloidogenic protection by lipoproteins
E Matsubara et al.
NEUROBIOLOGY OF AGING (2004)
Steep disturbances are correlated with decreased morning awakening salivary cortisol
J Backhaus et al.
PSYCHONEUROENDOCRINOLOGY (2004)
Evidence for peripheral clearance of cerebral Aβ protein following chronic, active Aβ immunization in PSAPP mice
CA Lemere et al.
NEUROBIOLOGY OF DISEASE (2003)
The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: Recent challenges and their implications for novel drug development
AV Terry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Memantine for the treatment of dementia
GK Wilcock
LANCET NEUROLOGY (2003)
Memantine in moderate-to-severe Alzheimer's disease
B Reisberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-3R)aminoindan-5-YL)-ethyl methyl carbamate
MBH Youdim et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2001)
Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments
AD Alonso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Inflammatory mechanisms in Alzheimer's disease:: Inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists
CK Combs et al.
JOURNAL OF NEUROSCIENCE (2000)
分享论文
